Evidence map›Paper›PMID 23887180›Full record

ArticleNature protocols2013

Site-specific protein labeling using PRIME and chelation-assisted click chemistry.

Chayasith Uttamapinant, Mateo I Sanchez, Daniel S Liu, Jennifer Z Yao, Alice Y Ting

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 86 citations in OpenAlex.

  1. Visualization of membrane-stabilized SorCS2Journal of structural biology: X · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Lipoic acid attachment to proteins: stimulating new developments.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chayasith UttamapinantDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Mateo I Sanchez
Daniel S Liu
Jennifer Z Yao
Alice Y Ting
Massachusetts Institute of Technology · USMarker Gene Technologies (United States) · US

Funding

Specific protein labeling in cells with engineered BirAR01GM072670 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI TING, ALICE Y · 2005 to 2013
$2.7M
NIGMS NIH HHS R01 GM072670
6 · The paper itself

Abstract

This protocol describes an efficient method to site-specifically label cell-surface or purified proteins with chemical probes in two steps: probe incorporation mediated by enzymes (PRIME) followed by chelation-assisted copper-catalyzed azide-alkyne cycloaddition (CuAAC). In the PRIME step, Escherichia coli lipoic acid ligase (LplA) site-specifically attaches a picolyl azide (pAz) derivative to a 13-aa recognition sequence that has been genetically fused onto the protein of interest. Proteins bearing pAz are chemoselectively derivatized with an alkyne-probe conjugate by chelation-assisted CuAAC in the second step. We describe herein the optimized protocols to synthesize pAz to perform PRIME labeling and to achieve CuAAC derivatization of pAz on live cells, fixed cells and purified proteins. Reagent preparations, including synthesis of pAz probes and expression of LplA, take 12 d, whereas the procedure for performing site-specific pAz ligation and CuAAC on cells or on purified proteins takes 40 min-3 h.

Indexed as

AlkynesAzidesChelating AgentsCopperCycloaddition ReactionEscherichia coliEscherichia coli ProteinsHEK293 CellsHumansLigasesMembrane ProteinsProteinsStaining and LabelingAlkynesAzidesChelating AgentsCopperEscherichia coli ProteinsLigaseslplA protein, E coliMembrane ProteinsProteins

Identifiers

PMID23887180
PMCPMC4892701
OpenAlexW2012730806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.